These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6644326)

  • 1. A therapeutic trial of gangliosides and thymosin in the Wobbler mouse model of motor neuron disease.
    Lange DJ; Good PF; Bradley WG
    J Neurol Sci; 1983 Oct; 61(2):211-6. PubMed ID: 6644326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse).
    Kozachuk WE; Mitsumoto H; Salanga VD; Beck GJ; Wilber JF
    J Neurol Sci; 1987 May; 78(3):253-60. PubMed ID: 3108458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal regeneration in wobbler motor neuron disease: quantitative histologic and axonal transport studies.
    Mitsumoto H
    Muscle Nerve; 1985 Jan; 8(1):44-51. PubMed ID: 2414649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of rat hypoglossal nerve regeneration by chitin sheet plus gangliosides.
    Itoh M; Fukumoto S; Baba N; Cho R; Kuga Y; Mizuno A; Furukawa K
    Br J Plast Surg; 2000 Oct; 53(7):607-11. PubMed ID: 11000078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuolated anterior horn cells in wobbler mouse motor neuron disease: peripheral axons and regenerative capacity.
    Mitsumoto H; Boggs AL
    J Neuropathol Exp Neurol; 1987 Mar; 46(2):214-22. PubMed ID: 3819775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease.
    Vacca-Galloway LL; Steinberger CC
    J Neurosci Res; 1986; 16(4):657-70. PubMed ID: 2432278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    J Neurol Sci; 1998 Sep; 160(1):9-15. PubMed ID: 9804111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced branching and length of dendrites detected in cervical spinal cord motoneurons of Wobbler mouse, a model for inherited motoneuron disease.
    Ma WY; Vacca-Galloway LL
    J Comp Neurol; 1991 Sep; 311(2):210-22. PubMed ID: 1721631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired slow axonal transport in wobbler mouse motor neuron disease.
    Mitsumoto H; Gambetti P
    Ann Neurol; 1986 Jan; 19(1):36-43. PubMed ID: 3947038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides. Their role in clinical neurology.
    Nobile-Orazio E; Carpo M; Scarlato G
    Drugs; 1994 Apr; 47(4):576-85. PubMed ID: 7516857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases.
    Bradley WG
    Muscle Nerve; 1990 Sep; 13(9):833-42. PubMed ID: 2233870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.
    Gorio A; Lesma E; Madaschi L; Di Giulio AM
    J Neurochem; 2002 Apr; 81(1):194-202. PubMed ID: 12067233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators in the neuromuscular system of the wobbler mutant mouse.
    Blondet B; Barlovatz-Meimon G; Festoff BW; Soria C; Soria J; Rieger F; Hantai D
    Brain Res; 1992 May; 580(1-2):303-10. PubMed ID: 1504807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron.
    Mitsumoto H; Bradley WG
    Brain; 1982 Dec; 105 (Pt 4)():811-34. PubMed ID: 7139256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice.
    Dave KR; Prado R; Busto R; Raval AP; Bradley WG; Torbati D; Pérez-Pinzón MA
    Neuroscience; 2003; 120(1):113-20. PubMed ID: 12849745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.